Connection

Daniel Judge to Animals

This is a "connection" page, showing publications Daniel Judge has written about Animals.
Connection Strength

0.448
  1. The Role of Genetics in Peripartum Cardiomyopathy. J Cardiovasc Transl Res. 2017 Dec; 10(5-6):437-445.
    View in: PubMed
    Score: 0.045
  2. Further evidence of harm from exercise in ARVD/C. J Am Coll Cardiol. 2015 Apr 14; 65(14):1451-3.
    View in: PubMed
    Score: 0.038
  3. Mutations in Alstr?m protein impair terminal differentiation of cardiomyocytes. Nat Commun. 2014 Mar 04; 5:3416.
    View in: PubMed
    Score: 0.035
  4. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. Am J Cardiovasc Drugs. 2011 Oct 01; 11(5):287-94.
    View in: PubMed
    Score: 0.030
  5. The mitral valve in hypertrophic cardiomyopathy: old versus new concepts. J Cardiovasc Transl Res. 2011 Dec; 4(6):757-66.
    View in: PubMed
    Score: 0.030
  6. Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res. 2011 Dec; 4(6):741-7.
    View in: PubMed
    Score: 0.029
  7. DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet. 2006 Jul; 79(1):136-42.
    View in: PubMed
    Score: 0.020
  8. Marfan's syndrome. Lancet. 2005 Dec 03; 366(9501):1965-76.
    View in: PubMed
    Score: 0.020
  9. Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy. Int J Mol Sci. 2022 Nov 11; 23(22).
    View in: PubMed
    Score: 0.016
  10. Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy. Sci Transl Med. 2021 02 17; 13(581).
    View in: PubMed
    Score: 0.014
  11. The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice. Hum Mol Genet. 2021 01 06; 29(21):3504-3515.
    View in: PubMed
    Score: 0.014
  12. Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency. PLoS Genet. 2019 10; 15(10):e1008354.
    View in: PubMed
    Score: 0.013
  13. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. Circulation. 2019 10 29; 140(18):1491-1505.
    View in: PubMed
    Score: 0.013
  14. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. J Clin Invest. 2019 07 02; 129(8):3171-3184.
    View in: PubMed
    Score: 0.013
  15. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy. Cell Rep. 2017 01 10; 18(2):571-582.
    View in: PubMed
    Score: 0.011
  16. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife. 2015 10 27; 4.
    View in: PubMed
    Score: 0.010
  17. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015 May 05; 131(18):1590-8.
    View in: PubMed
    Score: 0.010
  18. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med. 2014 Jun 11; 6(240):240ra74.
    View in: PubMed
    Score: 0.009
  19. Angiotensin II-dependent TGF-? signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014 Jan; 124(1):448-60.
    View in: PubMed
    Score: 0.009
  20. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation. 2014 Mar 11; 129(10):1092-103.
    View in: PubMed
    Score: 0.009
  21. A Pkd1-Fbn1 genetic interaction implicates TGF-? signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2014 Jan; 25(1):81-91.
    View in: PubMed
    Score: 0.009
  22. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset. Am J Med Genet A. 2013 Jul; 161A(7):1599-611.
    View in: PubMed
    Score: 0.008
  23. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome. PLoS One. 2012; 7(9):e44639.
    View in: PubMed
    Score: 0.008
  24. Translational research on the mitral valve: from developmental mechanisms to new therapies. J Cardiovasc Transl Res. 2011 Dec; 4(6):699-701.
    View in: PubMed
    Score: 0.007
  25. Noncanonical TGF? signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011 Apr 15; 332(6027):358-61.
    View in: PubMed
    Score: 0.007
  26. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science. 2011 Apr 15; 332(6027):361-5.
    View in: PubMed
    Score: 0.007
  27. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res. 2007 Aug 31; 101(5):512-22.
    View in: PubMed
    Score: 0.006
  28. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006 Apr 07; 312(5770):117-21.
    View in: PubMed
    Score: 0.005
  29. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004 Dec; 114(11):1586-92.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.